Remember last year when we told you about how ballplayers are using a spray made from ground up deer antlers as some sort of performance enhancer? And then about how Major League Baseball sent a warning to players that they shouldn’t use a particular brand of the deer antler spray because it could lead to positive drug test results due to contamination of some kind?
Yeah, the manufacturer didn’t like that, and now they’ve sued Major League Baseball:
Nutronics Labs alleges that, last summer, the league told its players to stop taking what became one of the latest performance enhancers so as not to risk testing positive for methyltestosterone, even though it wasn’t listed as an ingredient. As a result of what the company calls “false, misleading and malicious” statements by MLB, Nutronics says its business was significantly damaged and as much as $50 million in business could have been lost.
“We were getting calls left and right,” said Dr. Richard Lentini, CEO of Nutronics Labs. “People wanted refunds. We kept telling them that what baseball [league] was saying wasn’t the truth. But we’re the little guy, they wouldn’t believe us.”
And another march to court begins. Can’t wait until Andy Pettitte flip-flops on the stand in this one. Although maybe he’ll be disqualified as a witness based on where he lives in the offseason.
Yankees top prospect Gleyber Torres will be promoted to the majors this weekend, per a report from Jack Curry of the YES Network. Torres was expected to make his debut earlier in the season, but his starting date was pushed back after he suffered a bout of back tightness last Monday. Now, however, it looks like he’s finally healthy enough to make an impact on a team that’s in sore need of an offensive boost. As of Saturday evening, the team has yet to officially confirm the move.
The 21-year-old infielder has made quite the impression in Triple-A Scranton/Wilkes-Barre this spring, slashing .370/.415/.543 with five extra-base hits and 11 RBI in his first 53 plate appearances. Prior to the start of the 2018 season, he was ranked first overall in the Yankees’ system and fifth among the league’s best prospects (via MLB Pipeline). His numbers at the plate have been made all the more impressive by the fact that he’s only 10 months removed from Tommy John surgery on his non-throwing arm; neither the injury nor the lengthy recovery process seems to have had any detrimental effect on his game play this year.
While Torres appears most comfortable as a shortstop, he’s not expected to supplant Didi Gregorius in a starting role. Instead, it’s more likely that he’ll sub in at second and third base among the likes of Miguel Andujar, Neil Walker and Ronald Torreyes.